Connect with us

Health

WHO expands recommended contraceptive options, backs longer-lasting methods

info

Published

on

Different types of contraception.jpg

The World Health Organisation (WHO) has recommended an expanded range of contraceptive options, including longer use of some existing methods, mifepristone for emergency contraception and the development of new contraceptives for men.

The recommendations are contained in a new publication, “WHO guidelines on expanding contraceptive options”, aimed at helping countries broaden access to contraceptive methods supported by available scientific evidence.

WHO said the expansion was necessary to give people more options when deciding whether to use contraception, which method to use, and when to change or stop a method.

The global health body estimates that 164 million women who want to delay or avoid pregnancy are not currently using contraception.

Longer use of existing methods

Under the new guidance, WHO recommends that combined oral contraceptive pills may be taken for extended periods of up to six months or continuously for up to one year, instead of the conventional cyclical use.

The organisation also supports the use of contraceptive implants for up to five years, saying this could reduce the frequency of replacement procedures, clinic visits and associated costs.

PT WHATSAPP CHANNEL
Dangote Refinery AD

WHO also recommends mifepristone as an additional emergency contraceptive option.

It said mifepristone should be taken as soon as possible and within five days of unprotected sex.

According to the organisation, available evidence indicates that mifepristone at doses of 10 to 50 milligrams is likely to be as safe and effective as other emergency contraceptive methods.

Speaking on the need to expand contraceptive choices, Pascale Allotey, Director of WHO’s Department of Sexual, Reproductive, Maternal, Child and Adolescent Health and Ageing, said contraception should reflect people’s different needs and circumstances.

She said the choice of a contraceptive method should take into account factors including convenience, invasiveness, behaviour, reliability and accessibility.

“Choice is a gender equality issue,” Ms Allotey said, adding that contraception was not “one-size-fits-all”.

She noted that people should have the confidence and control to choose a contraceptive method, change it or stop using it.

WHO cautions against some contraceptive methods

While expanding the range of recommended methods, WHO said there was insufficient evidence to support some contraceptives for inclusion in family planning programmes.

The organisation called for further research into ormeloxifene before it is included in family planning programmes, citing limited evidence on its safety.

It also recommended against adding quinestrol-containing contraceptive pills to national contraceptive programmes because of limited evidence and reports of serious adverse events.

Push for male contraceptives

WHO said expanding contraceptive choices should also include methods that allow men to take greater responsibility for preventing pregnancy.

Currently, the main contraceptive methods under men’s direct control are condoms, withdrawal and vasectomy.

Despite the limited options, WHO said about 30 per cent of couples rely on a male method of contraception.

The organisation said its research challenges the longstanding assumption that men would not use new contraceptive methods.

More than 75 per cent of couples surveyed said they would be willing to use a new male contraceptive, while more than 85 per cent of women said they would trust their male partners to take responsibility for contraception.

To support the development of new methods, WHO has developed its first Target Product Profile for male contraceptives.

The profile outlines characteristics that future male contraceptive methods should aim to meet, including safety, effectiveness, acceptability and affordability.

READ ALSO: WHO urges safer care for people living with noncommunicable diseases

WHO said the profile is intended to provide researchers, funders and developers with clearer direction while helping to shape a contraceptive market that reflects users’ needs.

New male contraceptives in development

Several hormonal and non-hormonal male contraceptive methods are currently being researched, with some candidates in advanced clinical trials.

WHO said this suggests that new reversible male contraceptives could reach the market within the next five to 10 years.

The organisation said it would continue supporting countries to update their policies and family planning programmes in line with the best available scientific evidence.


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

British national tests positive for Ebola in DRC

info

Published

on

Doctors handling an Ebola case 1.jpg

A British national has tested positive for Ebola in the Democratic Republic of the Congo (DRC), the UK government has confirmed.

According to the BBC, the British man tested positive for the virus while in the DRC. Reuters subsequently reported that he would be medically evacuated to the UK for specialist treatment. However, the exact time of the evacuation was not immediately known.

This marks the first confirmed case of a British national contracting the virus during the ongoing outbreak in the DRC, which has claimed more than 5,000 lives.

Ebola is a viral disease that can cause severe illness and spreads mainly through direct contact with the blood or other bodily fluids of an infected person.

Symptoms include fever, headache, vomiting, muscle pain, weakness, and diarrhoea.

“The UK has well-established procedures for dealing with cases like this, and those processes have been activated,” a UK government spokesperson was quoted as saying.

“Further information will be shared in due course as appropriate. The risk to the UK public from Ebola remains low.”

Ebola outbreak

The current outbreak is caused by the Bundibugyo virus, a species of Ebola virus, and was first declared in DRC in May 2026.

According to the latest figures from the United States Centres for Disease Control and Prevention (CDC), the outbreak had recorded 10,563 confirmed cases and 5,130 deaths across five countries as of 1 November 2026.

The DRC accounts for the majority of the cases, with 10,532 confirmed cases and 5,126 deaths. The outbreak has affected eight provinces in the country.

Kenya has recorded nine confirmed cases and two deaths, while Uganda has recorded 20 confirmed cases and two deaths, alongside one probable case and one probable death.

Nigeria confirmed its first case on 20 October after a traveller with a history of travel to Uganda tested positive for the virus. The patient was subsequently medically evacuated to Switzerland for treatment.

According to the European Centre for Disease Prevention and Control (ECDC), 62 contacts linked to the Nigerian case had been identified and were under follow-up as of 29 October.

Symptoms and transmission

The World Health Organisation (WHO) has explained that Ebola survivors may transmit the virus through sexual intercourse if it persists in their semen after recovery.

However, survivors who have met the criteria for discharge from treatment are not expected to transmit the virus through sweat or saliva, as the virus is cleared from their blood.

Continue Reading

Health

Six climate measures could save 1.6 million lives yearly – WHO

info

Published

on

World Health Organisation.jpg

Six proven climate and health interventions could prevent 1.6 million deaths annually and generate trillions of dollars in economic benefits if implemented globally, the World Health Organisation (WHO) has revealed.

The measures, which include heat-health warning systems, access to safe water and sanitation, cleaner household energy and more efficient fossil fuel pricing policies, could generate $3.9 trillion in annual economic welfare benefits and a further $5.4 trillion in fiscal gains.

The WHO disclosed this in a new report titled ‘Global benefits and costs of prioritised actions on climate change and health’, released ahead of the 31st United Nations Climate Change Conference (COP31), where countries are expected to present their climate commitments.

According to the report, the six interventions could prevent one in every 40 deaths globally, based on modelled projections, while avoiding 16.7 billion tonnes of carbon dioxide emissions annually.

The estimated emissions reduction is equivalent to 31 per cent of global annual greenhouse gas emissions, excluding emissions from land use, land-use change and forestry.

The report, which the WHO described as its first comprehensive assessment of the economic and fiscal returns from scaling up the six recommended interventions, highlights the potential health and financial gains of integrating public health considerations into climate policies.

PT WHATSAPP CHANNEL
Dangote Refinery AD

It argues that many health consequences of climate change are preventable through existing solutions, but governments must implement them across health and other sectors that determine people’s health.

Six interventions

The report identifies six interventions: heat-health warning systems, climate-resilient drinking-water services, basic sanitation services, hygiene and handwashing facilities, cleaner household fuels and technologies for cooking and heating, and efficient fossil fuel pricing policies.

The WHO estimates that five of the interventions could generate $24 in benefits for every $1 invested, with returns expected to be greater in low- and middle-income countries.

Heat-health warning systems are projected to deliver particularly high returns, generating an estimated $835 in benefits for every $1 invested.

The report attributes the high returns to the relatively low cost of expanding existing warning systems and their potential to prevent heat-related illnesses.

Efficient fossil fuel pricing policies, however, are projected to deliver the largest overall gains.

Such policies, including removing inefficient fossil fuel subsidies and appropriately taxing fossil fuels, could prevent 1.2 million deaths annually while generating $3 trillion in economic welfare benefits and $5.4 trillion in fiscal gains.

Health at the centre of climate action

Commenting on the findings, WHO Director-General Tedros Ghebreyesus said the climate crisis was also a health crisis, but many of its consequences could be prevented using existing interventions.

READ ALSO: WHO raises alarm as 75% of diabetes cases in Africa remain undiagnosed

He said expanding proven and affordable interventions could save millions of lives, particularly in countries with the greatest need.

“The climate crisis is a health crisis, but much of the harm it causes can be prevented with tools we already have,” he said.

Mr Ghebreyesus urged governments to place health considerations at the centre of climate action as they prepare for the next round of international climate negotiations.

The WHO said countries were already experiencing record-breaking climate shocks in 2026, investing in measures that protect human health and the environment increasingly urgent.

The health body called on governments, development partners and financing institutions to use the economic evidence to scale up the interventions, noting that they could deliver simultaneous benefits for public health, climate mitigation and national economies.


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading

Trending